Risk of anaphylactic reaction associated with glatiramer acetate, used to treat multiple sclerosis
See all recalls from Risk →Recalled Product
Glatiramer acetate
✅ What Should You Do?
- ⚠️ Stop using this product until you have checked the recall details below.
- Follow the instructions from the issuing agency (see below).
- 💰 Check if you are eligible for a refund or free replacement from the retailer or manufacturer.
- 📋 Report a product safety incident to Health Canada
Looking for a safe alternative?
Search Amazon Canada for Glatiramer acetate →
Hazard / Issue
Product safety - New safety information
Issued by
Communications and Public Affairs Branch
⚠️ What You Should Do
If you experience anaphylactic reaction symptoms, stop taking glatiramer acetate and seek immediate medical help by calling 9-1-1.Do not restart taking glatiramer acetate if you have experienced anaphylaxis unless your healthcare provider has identified another clear cause for the anaphylaxis.Report any health product-related side effects to Health Canada.What healthcare professionals should doInform patients and/or caregivers of the signs and symptoms of anaphylactic reactions, which may overlap with those of an immediate post-injection reaction.Instruct patients to seek immediate emergency medical care in the event of an anaphylactic reaction.Instruct patients to discontinue treatment with glatiramer acetate if they have an anaphylactic reaction.Do not restart the medicine unless there is another clear reason the patient experienced an anaphylactic reaction.
⚖️ Were You Affected?
If you were injured or suffered a loss due to this recalled product, you may have legal options.
Search for Class Action Lawyers →Consumer Recalls Canada is not a law firm and does not provide legal advice. We may receive a referral fee if you inquire. We are not affiliated with any law firm or legal service.
Get Canada's next recall alert before it hits the news.
Free. Weekly digest or instant alerts. Unsubscribe anytime.
CASL compliant · No spam · Unsubscribe anytime